These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 21280612)

  • 1. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.
    Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z
    Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A carrier-mediated prodrug approach to improve the oral absorption of antileukemic drug decitabine.
    Zhang Y; Sun J; Gao Y; Jin L; Xu Y; Lian H; Sun Y; Sun Y; Liu J; Fan R; Zhang T; He Z
    Mol Pharm; 2013 Aug; 10(8):3195-202. PubMed ID: 23822717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
    Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
    Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
    Anand BS; Katragadda S; Mitra AK
    J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE; Christensen MS; Bagger MA; Steffansen B
    Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
    Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
    Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
    Fisher SJ; Lee IJ; Swaan PW; Eddington ND
    Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
    Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
    Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
    Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
    J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs of 2',3'-dideoxyinosine (DDI): improved oral bioavailability via hydrophobic esters.
    Kawaguchi T; Hasegawa T; Seki T; Juni K; Morimoto Y; Miyakawa A; Saneyoshi M
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1338-40. PubMed ID: 1394659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells.
    Cheon EP; Hong JH; Han HK
    J Pharm Pharmacol; 2006 Jul; 58(7):927-32. PubMed ID: 16805952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
    Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
    Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
    Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.